Skip to main content

Table 2 Baseline characteristics of the 43 patients with mild drug-induced hepatotoxicity

From: Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis

  Patients with hepatoprotective drugs (N = 10) Patients without hepatoprotective drug (N = 33) P value
Sex    0.80
 Male 7 24  
 Female 3 9  
Age (years) 57 ± 21 55 ± 23 0.80
Peak AST (IU/dl) 66 ± 19 58 ± 12 0.20
Peak ALT (IU/dl) 72 ± 21 54 ± 21 0.058
  1. Data are expressed as number or means ± standard error
  2. AST aspartate aminotransferase, ALT alanine aminotransferase